Geovax Labs (GOVX) Expands and Strengthens Intellectual Property Portfolio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
GeoVax Expands and Strengthens Intellectual Property Portfolio
March 4, 2021 9:55 AM ESTFilings Made in Corporate Focus Areas of SARS-CoV-2 and Immuno-Oncology
Atlanta, GA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (GeoVax or the Company), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the filing of two additional patent applications important to the Companys key focus on vaccines... More
